‘Piece of Ramadan’ in Egyptian Museums

Egyptian museums display collections of historic artifacts and memorabilia on the occasion of Ramadan.
Egyptian museums display collections of historic artifacts and memorabilia on the occasion of Ramadan.
TT

‘Piece of Ramadan’ in Egyptian Museums

Egyptian museums display collections of historic artifacts and memorabilia on the occasion of Ramadan.
Egyptian museums display collections of historic artifacts and memorabilia on the occasion of Ramadan.

Egyptian museums are displaying collections of historic artifacts and memorabilia that highlight the heritage of the holy mosque under the theme “Piece of Ramadan”.

Running until the end of the holy month, the exhibitions feature rare Quran copies, lanterns, and personal memorabilia of princes and historic figures.

The Museum of Islamic Art (central Cairo) displays a Quran copy that dates back to the Umayyad era in the 2nd century of Hegira (8th century AD). According to the museum’s records, this copy, written in a simple kufi style and black ink, is “the oldest featuring shape tags and red notes.”

The Hurghada Museum displays several pieces including a lantern that belonged to Sultan Barquq, the first Sultan of the Circassian Mamluk dynasty of Egypt, who ruled from 784 until 801 Hegira (1382-1389 AD). The lantern is made of thick glass and features decorations.

Director of the Nile Palace Museum Muhammad al-Bardini said the museum is taking part in the celebrations of Ramadan’s historic ambiances with some pieces that belonged to the palace’s owner, Prince Mohammed Ali Tewfik.

The collection includes “a number of Quran copies, rosaries, and a silver fridge that was used by the prince and his family during Ramadan, in addition to a collection of prayer mats, and an ivory box featuring Al-Aqsa Mosque.”

“Displaying the artifacts and memorabilia related to the holy month is aimed at linking the present to the past, and recalling Ramadan stories of historic figures,” he told Asharq Al-Awsat. “The rare memorabilia of Prince Mohammed Ali Tewfik highlight his interest in Ramadan and its rituals,” he noted.

Many other Egyptian museums have also organized exhibitions on the occasion of Ramadan. Under the theme “Bring Lanterns, Kids”, the Museum of the Royal Vehicles in central Cairo displays a collection of historic memorabilia including two copper lanterns that date to the era of Mohamed Said Pasha, a silver fruit plate from the collection of the Muhammad Ali Dynasty, and a Victorian horse carriage that was dedicated for mosque visits.

The museum also screens a documentary that brief the visitors on Ramadan celebrations during the rule of the Muhammad Ali Dynasty.

The “Ahlan Ramadan” exhibition at the Nile Palace Museum displays 25 artifacts linked to the holy month, while the Kafr El Sheikh Museum in the Egyptian Delta hosts an exhibition dubbed “Ramadan Kareem.” It displays a Quran copy handwritten by Sheikh Mohammed Abdelaziz Al-Rifai in 1341 Hegira, in addition to paintings, two handwritten pages from a Quran, and a lantern featuring the name of Khedive Abbas II Helmy Bey.

As for the Museum of Royal Jewelry in Alexandria, it displays a rare picture of King Farouk performing the first Friday prayer in Ramadan, at the historic Rifai Mosque accompanied by eminent scholars and statesmen.



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”